Specifications
- Purity
- ≥98% (HPLC)
- Appearance
- White to off-white powder
- Identity
- 1H-NMR
Properties
- Solvents
- DMSO (30 mg/ml), DMF (50 mg/ml), ethanol (30 mg/ml)
Category: Phytochemicals
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
Prostaglandin E1 (PGE1) is an endogenous prostaglandin used as a medication. Its synthetic form, alprostadil, is a vasodilator and smooth muscle relaxant used for several different medical purposes. PGE1 is the theoretical cyclooxygenase metabolite of dihomo-γ,-linolenic acid (DGLA), but it is virtually undetectable in the plasma of normal humans or other animals. Its pharmacology includes vasodilation, hypotension and anti-platelet activities. The IC50 of PGE1 for the inhibition of ADP-induced human platelet aggregation is 40 nM. The vasorelaxant and anti-hypertensive effects of PGE1 are used to treat male erectile dysfunction and to provide emergency vasodilation of the patent ductus arteriosus in infants whose cardiac anomalies require pulmonary shunting for survival.
Synonyms | (11α,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-enoic acid, Alprostadil, PGE1 |
---|---|
Purity | ≥98% (HPLC) |
Appearance | White to off-white powder |
CAS-Number | 745-65-3 |
Molecular Formula | C20H34O5 |
Molecular Weight | 354.49 |
Identity | 1H-NMR |
Solvents | DMSO (30 mg/ml), DMF (50 mg/ml), ethanol (30 mg/ml) |
Smiles | O[C@@H]([C@H](/C=C/[C@@H](O)CCCCC)[C@H]1CCCCCCC(O)=O)CC1=O |
InChi Key | GMVPRGQOIOIIMI-DWKJAMRDSA-N |
Shipping | BLUE ICE |
Short Term Storage | -20°C |
Long Term Storage | -20°C |
Handling Advice | Protect from light and moisture. |
Use / Stability | Stable for at least 2 years after receipt when stored at -20°C. |
Hazard statements | H301-H361 |
Precautionary statements | P281-P301 + P310 |
GHS Symbol | GHS06+GHS08 |
Signal word | Danger |
RIDADR | UN2811 |
Transportation | Packing Group III |
References | (1) F. Okada, et al., Prostaglandins 7, 99 (1974), (2) P.M. Olley & F. Coceani, Ann. Rev. Med. 32, 375 (1981), (3) S.J. Kirtland, Prostaglandins Leukot. Essent. Fatty Acids 32, 165 (1988) (Review), (4) G. Kobzar, et al., Proceed. Est. Acad. Sci. Chem. 40, 179 (1991), (5) H. Padma-Nathan, et al., New Engl. J. Med. 336, 1 (1997), (6) W. Cawello, et al., J. Urol. 158, 1403 (1997) |
InChi | InChI=1S/C20H34O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h12-13,15-17,19,21,23H,2-11,14H2,1H3,(H,24,25)/b13-12+/t15-,16+,17+,19+/m0/s1 |
Quantity | 5 mg, 10 mg, Bulk |